AIRWA INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AIRWA INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	0.01	0.01	0	0.69	10.8	16.1	9.92	5.2	12.8	25.8
Cost of revenue	0	0		1.37	7.68	11.9	7.14	1.18	2.98	22.5
Gross profit	0.01	0.01		-0.68	3.12	4.22	2.78	4.02	9.84	3.34
Research and development				0.18	0.34	0.74	0.07
Selling, general and administrative		0
Selling and marketing		0		0.56	1.88	3.48	1.93	1.57		0.75
General and administrative	0	0	0.03	5.29	4.63	46.7	22.7	0.16	3.26	8.71
Operating expenses	0.01	0.02	0.03	6.23	6.85	50.9	24.7	0.16	3.26	9.46
Operating income	0	-0.01	-0.03	-6.92	-3.73	-46.7	-22	3.85	6.58	-6.12
Interest expense				0.57		0.11
Interest income								0.01	0.07	0.07
Other non-operating income				-2.31	-14.9	0.18	-3.32	-9.19
Pre-tax income		-0.01	-0.03	-9.23	-18.6	-46.5	-25.3	3.87	6.65	-18.6
Income tax								1.24	2.01	-1.08
Net income to minority interests									1.14
Net income	0	-0.01	-0.03	-9.23	-18.6	-51.8	-71.2	2.63	3.49	-17.6
EBITDA	0	-0.01	-0.03	-6.92	-3.72	-46.7	-10.4	5.03	9.56	-5.82
EPS, basic	0.00	0.00	0.00	-295.80	-5,564.00	-10,761.00	-5,085.00	0.23	10,843.00	-752.73
EPS, diluted	0.00	0.00	0.00	-295.80	-559.62	-10,761.00	-5,085.00	-32.44	10,843.00	-752.73
Shares, basic (weighted)	0.01	0.01	0.03	0.03	0	0	0.01	11.6	0	0.02
Shares, diluted (weighted)	0.01	0.01	0.01	0.03	0.03	0	0.01	11.6	0	0.02

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	0.02	0.02	0	0.08	0.93	0.67	0.2	0.04	0.05	12.8
Short-term investments								1.71	1.38
Receivables					0.76	1.03	0.4	4.94	15.4	18
Inventory				0.92	3.69	7.86	3.19	1.61
Other current assets	0	0	0	0.38	0.06	0.27	0.26	0.49	2.74	1.34
Total current assets		0.02	0	1.38	5.58	12.8	4.99	9.68	22.4	59.5
Property, plant and equipment			0			0.05	0.01			1.3
Goodwill						6.78				58.3
Intangible assets		0	0		0.11	4.84	0.1	13.5	10.5	91.3
Other non-current assets		0
Total assets	0.02	0.03	0.01	1.38	5.7	74.9	7.11	23.2	32.9	210
Accounts payable		0	0	0.97	1.04	5.25	5.5	0.05		4.99
Accrued liabilities		0	0	0.26	2.29	4.38	4.91	0.12	2.43	3.45
Deferred revenue				0.18	0.1	0.11				10.8
Total current liabilities		0	0.01	4.49	24.1	39	23.8	1.44	6.49	19.2
Long-term debt		0		0.39	0.01	2
Total liabilities	0.01	0.03	0.01	6.37	24.1	42.4	25.7	1.44	6.49	39.8
Paid-in capital	0	0.02	0.02	5.21	10.4	113	133	19.1	19.2	182
Retained earnings	0	-0	-0.03	-10.2	-28.8	-80.6	-152	2.63	6.12	-11.4
Other comprehensive income				-0.01	-0.02	0.05	0.14	0.18
Shareholders' equity	0.01	0.02	-0.01	-4.99	-18.5	32.5	-18.6	9.6	25.3	171
Minority interests									1.14
Total equity	0.01	0.02	-0.01	-4.99	-18.5	32.5	2.89	21.7	26.4	171
Total liabilities and equity	0.02	0.02	0.01	1.38	5.7	74.9	7.11	23.2	32.9	210
Shares outstanding	0.01	0.01	0.03	0.03	0	0.01	0.02	1.83	0	0.05

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	0	-0.01	-0.03	-9.23	-18.6	-51.8	-71.2	2.63	4.63	-17.6
Depreciation and amortization	0	0	0	0	0	0.04	11.6	1.18	2.98	0.31
Stock-based compensation				3.74	0.07	32.5	0.75		0.06
Deferred income tax										-1.08
Change in receivables					-0.76	-0.27	-1.37	-3.02	-12.1	-1.6
Change in inventory				-0.92	-2.76	-4.19	4.41	1.58
Change in payables	0.01	-0	-0	0.86						4.99
Cash from operations	0.01	-0.01	-0.03	-4.21	-4.52	-12.4	-6.37	0.04	-0.38	-20.9
Capital expenditures	0
Purchases of investments										-36
Cash from investing	-0	-0	0	0.07	-0.03	-1.62		-16.5		-164
Stock issued	0	0.02	0				8.74	18		5.77
Share buybacks		0	-0	-0.33
Cash from financing	0	0.02	0.01	4.22	5.42	13.7	5.82	-2.45	0.39	198
Net change in cash	0.01	0	-0.02	0.08	0.85	-0.25	-0.46	0.04	0.02	12.7
Free cash flow	0.01
Interest paid		0	0	0.22	0.26	0.22	0.48	0.71
Income taxes paid		0	0		0	0.11

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $0.79 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	15.3%	Gross profit / revenue.
Operating margin	-18.0%	Operating income / revenue.
Net margin	-43.9%	Net income / revenue.
Operating cash flow margin	17.9%	Cash from operations / revenue.
Return on equity (ROE)	-11.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-7.5%	Net income / average total assets.
Return on invested capital (ROIC)	-3.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	101.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	37.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	19.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-66.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	6.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-193.1%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-160.9%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-603.0%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-106.9%	EPS vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	574.8%	Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	539.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	209.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	105.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	7,145.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	18.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-6.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.58x	Current assets / current liabilities.
Quick ratio	0.35x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.19x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	33.2%	Total liabilities / total assets.
Working capital	-$24.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	86.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$52.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.17x	Revenue / average total assets.
Fixed asset turnover	35.6x	Revenue / average property, plant and equipment.
Inventory turnover	11.6x	Cost of revenue / average inventory.
Days inventory	31 days	365 x average inventory / cost of revenue.
Receivables turnover	4.99x	Revenue / average receivables.
Days sales outstanding	73 days	365 x average receivables / revenue.
Days payables	43 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	62 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$366.92	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$836.24	Revenue / diluted weighted shares.
Operating cash flow per share	$149.98	Cash from operations / diluted weighted shares.
Book value per share	$3,228.00	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1,005.00	Tangible book value / shares outstanding.
Cash per share	$210.43	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$41.8K	Share price x shares outstanding.
Enterprise value	-$11.0M	Market cap + total debt - cash - short-term investments.
P/S	0.00x	Market cap / revenue.
P/B	0.00x	Market cap / shareholders' equity. Only when equity is positive.
P/OCF	0.01x	Market cap / cash from operations, when positive.
Earnings yield	-46,241.0%	Net income / market cap (the inverse of P/E).

What was AIRWA INC.'s revenue in fiscal 2026?

AIRWA INC. reported revenue of $25.8M for fiscal 2026, 101.3% higher than the year before.

Was AIRWA INC. profitable in fiscal 2026?

No. It reported a net loss of $17.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AIRWA INC.